MED12 and small cell lung carcinoma: Based on the aforementioned findings, the primary objective of this study was therefore to identify the association between disease-specific survival and protein expression of various molecules including RTKs, MED12, and TGF-βRII by immunohistochemistry (IHC) so as to find a prognostic marker in early-stage SCLC.